EMERYVILLE, Calif.–(BUSINESS WIRE)–NovaBay® Pharmaceuticals, Inc. (NYSE MKT: NBY), a biopharmaceutical company focusing on commercializing its prescription Avenova® lid and lash hygiene product for the domestic eye care market, announces that it will report second quarter 2016 financial results after market close on Thursday, August 11. Management will hold an investment community conference call that day to discuss financial results and provide a Company update. DATE: Thursday, August
BEDFORD, Mass.–(BUSINESS WIRE)–Ocular Therapeutix, Inc. (NASDAQ: OCUL), a biopharmaceutical company focused on the development and commercialization of innovative therapies for diseases and conditions of the eye, today provided an update on the status of its New Drug Application (NDA) for DEXTENZA™ (dexamethasone insert) 0.4 mg, for intracanalicular use in the treatment of ocular pain occurring after ophthalmic surgery. On July 25, 2016, Ocular Therapeutix announced that it received a Complet
NEW YORK–(BUSINESS WIRE)–Ophthotech today announced financial results for the second quarter ended June 30, 2016 and provided an update on the Company’s business and product development programs.
INDIANAPOLIS–(BUSINESS WIRE)–Contact lens users opting for LASIK are more satisfied with their vision over time than those who stay in contacts according to first of its kind research study.
NEW YORK–(BUSINESS WIRE)–Ophthotech today announced the election of Ian F. Smith, Executive Vice President and Chief Financial Officer of Vertex Pharmaceuticals, to its Board of Directors, effective immediately.
LEXINGTON, Mass.–(BUSINESS WIRE)–Inotek Pharmaceuticals Corporation (NASDAQ:ITEK) today announced the pricing of an underwritten public offering of $50.0 million aggregate principal amount of 5.75% Convertible Senior Notes due 2021.
LAGUNA HILLS, Calif.–(BUSINESS WIRE)–Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures designed to transform the treatment of glaucoma, …
SAN JUAN CAPISTRANO, Calif.–(BUSINESS WIRE)–Allegro Ophthalmics, LLC, a late stage biotechnology company focused on the development of therapies to treat vitreoretinal diseases, today announced that Ron Kurtz, MD, president and CEO of Calhoun Vision, and Mark Livingston, president and CEO of PrimaPharma, have been elected to Allegro’s board of directors. “Ron and Mark bring tremendous operational, financial and leadership expertise and experience to Allegro,” said Hampar Karageozian, MSc, MBA
DUBLIN–(BUSINESS WIRE)–Research and Markets has announced the addition of the “Europe Retinitis Pigmentosa Market and Competitive Landscape Highlights – 2016” report to their offering. Europe Retinitis Pigmentosa Market and Competitive Landscape High…
SYLMAR, Calif.–(BUSINESS WIRE)–Second Sight Medical Products, Inc. (NASDAQ:EYES) (“Second Sight” or “the Company”), a developer, manufacturer and marketer of implantable visual prosthetics to provide some useful vision to blind patients, today report…
SYLMAR, Calif.–(BUSINESS WIRE)–Second Sight Medical Products, Inc. (NASDAQ:EYES) (“Second Sight” or “the Company”), a developer, manufacturer and marketer of implantable visual prosthetics to restore some useful vision to blind patients, today announced plans to expand into Taiwan with Orient Europharma Co, Ltd. and Iran with Arshia Gostar Darman Co, Ltd. through exclusive agreements to distribute the Argus® II Retinal Prosthesis System (“Argus II”). In Taiwan, Orient Europharma is a well-est
IRVINE, Calif.–(BUSINESS WIRE)–Aerie Pharmaceuticals, Inc. (Nasdaq:AERI), (the “Company”), announced today that its second quarter 2016 financial results will be released after the market closes on Wednesday, August 3, 2016. Following the release, the Company will host a live conference call and webcast at 5:00 p.m. Eastern Time to discuss the Company’s financial results and provide a general business and strategic update. The live webcast and a replay may be accessed by visiting the Company’
THOUSAND OAKS, Calif.–(BUSINESS WIRE)–Fichte, Endl & Elmer Eyecare Selects Compulink’s EHR, Practice Management and ASC Solution to Support its Comprehensive Eye Care Practice.
LONDON–(BUSINESS WIRE)–#Healthcare–Technavio analysts forecast the global monoclonal antibodies (mAbs) market to grow at a steady CAGR of close to 10% during the forecast period, according to their latest report.
BEDFORD, Mass.–(BUSINESS WIRE)–Ocular Therapeutix, Inc. (NASDAQ:OCUL), a biopharmaceutical company focused on the development and commercialization of innovative therapies for diseases and conditions of the eye, today announced that it received a Complete Response Letter (CRL) from the U.S. Food and Drug Administration (FDA) regarding its New Drug Application (NDA) for DEXTENZA™ (dexamethasone insert) 0.4 mg, for intracanalicular use in the treatment of ocular pain occurring after ophthalmic
LAKE FOREST, Calif.–(BUSINESS WIRE)–ReVision Optics, Inc., a leader in implantable presbyopia-correcting corneal inlay technology, announces the appointment of Frank Shields to the newly created position of Vice President of Sales Worldwide effective…
DUBLIN–(BUSINESS WIRE)–Research and Markets has announced the addition of the “Ophthalmology Devices Market – Market Share Analysis & Global Forecasts to 2021” report to their offering. The global ophthalmology devices market is projected to reach USD 58.05 billion by 2021, at a CAGR of 3.7% during the forecast period of 2016 to 2021. The growth in this market is majorly driven by the increasing geriatric population and related increase in the prevalence of eye diseases. In this report, t
LEXINGTON, Mass.–(BUSINESS WIRE)–Inotek Pharmaceuticals (NASDAQ: ITEK) expands intellectual property portfolio with combination patent of trabodenoson with a prostaglandin analog for the treatment of intraocular pressure (IOP).
SEOUL, South Korea–(BUSINESS WIRE)–Dr. Oh has succeeded in the research of LASEK on reduction of eye damage.
HONG KONG–(BUSINESS WIRE)–Cigna has unveiled its first ever regional brand campaign for key international markets, designed to showcase the company’s capabilities and the solutions it delivers for customers. The campaign, themed “All The Way, Means All The Way,” builds on Cigna’s global wellness mission to improve customers’ health, well-being and sense of security and is being rolled out in an integrated digital marketing format across multiple markets internationally. The series of advertis